Articles by Daniel Marsh
Paranovus Stock Surges 620% After Filing for $195 Million Share Sale
Paranovus shares skyrocketed 620% to $6.76 after filing to sell up to $195 million in new stock, far exceeding its market cap, raising significant dilution risks.
AEP Boosts Capital Plan to $78B as Data Center Demand Surges
American Electric Power has increased its five-year capital plan to $78 billion, driven by 7 GW of new data center agreements. The company expects 63 GW of incremental load by 2030, with nearly 90% from data centers.
Smart Logistics Global Soars 159% Before Nasdaq Volatility Halt
Smart Logistics Global surged 159% to $1.33 before a Nasdaq volatility pause, pushing the stock above the $1 minimum bid-price needed for compliance.
Autozi Stock Surges 400% After Reverse Split, But Going Concern Warning Looms
Autozi shares jumped over 400% to $5.69 after a reverse split, but the company reported a 63% revenue decline and warned of substantial doubt about its ability to continue.
Redwire Stock Drops 6.5% on $500M ATM Offering Plan
Redwire Corp shares fell 6.5% to $17.37 after filing a $500M at-the-market stock program, raising dilution concerns despite record backlog and strong revenue growth.
GSK's $10.6B Nuvalent Bid Drives Stock Near Offer Price
Nuvalent shares jumped 38.9% to $122.93 after GSK's $10.6 billion buyout offer, as investors bet on the deal closing with two lead lung-cancer drugs under FDA review.
AT&T Shares Edge Up as $45B Payout Plan and 2026 Guidance Hold Steady
AT&T shares edged up pre-market after reaffirming 2026 targets and a $45B+ payout plan, providing a cash-flow marker as satellite broadband competition looms.
GSK Acquires Nuvalent for $10.6B in Oncology Push Ahead of HIV Patent Cliff
GSK buys Nuvalent for $10.6B, paying a 40% premium, to strengthen its oncology portfolio and offset upcoming HIV drug patent losses.
